title: Failure of danaparoid anticoagulation for cardiopulmonary bypass.
authors.affiliation: Department of Pharmacy, St Boniface General Hospital, Winnipeg, Manitoba, Canada. rariano@gwmail.sbgh.mb.ca
authors.forename: R E
authors.initials: RE
authors.lastname: Ariano
authors.forename: S K
authors.initials: SK
authors.lastname: Bhattacharya
authors.forename: M
authors.initials: M
authors.lastname: Moon
authors.forename: L G
authors.initials: LG
authors.lastname: Brownell
mesh_terms: D000368:Aged; D000789:Angina, Unstable / Q000188:drug therapy / Q000209:etiology; D000925:Anticoagulants / Q000627:therapeutic use*; D002315:Cardiopulmonary Bypass; D002809:Chondroitin Sulfates / Q000627:therapeutic use*; D003327:Coronary Disease / Q000150:complications / Q000601:surgery*; D003871:Dermatan Sulfate / Q000627:therapeutic use*; D004338:Drug Combinations; D006493:Heparin / Q000009:adverse effects*; D006497:Heparan Sulfate / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D012086:Reoperation; D013921:Thrombocytopenia / Q000139:chemically induced / Q000188:drug therapy; D013927:Thrombosis / Q000139:chemically induced / Q000188:drug therapy; D017211:Treatment Failure
chemical_list: D000925:Anticoagulants; D002809:Chondroitin Sulfates; D003871:Dermatan Sulfate; D004338:Drug Combinations; D006493:Heparin; D006497:Heparan Sulfate; C035838:danaparoid